ScaleReady

We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady?, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration

The biotech industry is facing a talent shortage. But did you know that decentralized manufacturing can help address this issue? In this BioProcess International podcast episode, Josh Ludwig and Germfree explore how a more distributed model can develop a stronger talent pipeline. https://lnkd.in/gnpNKDPa #biotech #sustainability #manufacturing #cellandgenetherapy #patientcare #scaleready #talent #biotechjobs

The potential of cell and gene therapy is limitless. But to realize its full potential, we need to address key challenges. This Drug Discovery World article explores these challenges and Josh Ludwig highlights how ScaleReady is working to overcome them. Don't miss it! Read the full article: https://lnkd.in/eX-_e_rc #CGT #CellTherapy #Innovation

Happy World Kindness Day! ?? Let's embrace kindness as the norm by performing a random act of kindness today. Share your act of kindness in the comments to inspire others and contribute to normalizing kindness around the world. ?? 7 ways to start making kindness the norm in your life: https://lnkd.in/gUZb3ng #WorldKindnessDay

Are you in the cell and gene therapy industry? You won't want to miss this! Ignacio Nunez, COO of CellReady?, talks about the company's latest projects and the future of the industry in a recent interview. Watch now and share your thoughts! https://lnkd.in/eCj_gmb3 #cellandgenotherapy #biotech #innovation #watchnow

Join us at Booth #927 at SITC in Houston this week to learn about the G-Rex Grant Program, an exciting initiative designed to support innovative research in cell therapy and immunotherapy. This program provides funding and resources to researchers and manufacturers committed to pushing the boundaries of cancer treatment. The G-Rex platform simplifies suspension cell expansion and manufacturing, enabling researchers and manufacturers alike to focus on what matters most—developing effective therapies. Whether you’re exploring new applications or refining existing methods, our grant program can help you turn your ideas into reality. Don’t miss this opportunity! Visit us to find out how you can apply and be part of the future of cancer care. See you there! #SITC #cellandgenetherapy #celltherapy #innovation

Big Pharma is all in on cell therapy manufacturing! As featured in Pharma's Almanac, the demand for CGT therapies is skyrocketing, driving significant investment in manufacturing capabilities. Read the full article to learn how we're at the forefront of helping companies navigate this complex landscape according to Josh Ludwig, Global Director, ScaleReady: https://lnkd.in/g3C3Dj7B #celltherapy #manufacturing #pharma #biotech #scaleready #pharmasalmanac

Did you miss this all-star lineup is coming together for our ISCT, International Society for Cell & Gene Therapy 2024 Corporate Session? Don't worry! Watch industry leaders from Cellular Origins, Germfree, and CellReady share their expertise on redefining sustainability in CGT here: https://bit.ly/4fqQ11K #CGT #Sustainability #ISCT2024 #celltherapy

In November, we observe National Family Caregivers Month—a moment to acknowledge and honor the family caregivers who hold a special place in our hearts. Join us in raising awareness of caregiving issues, educating communities, and enhancing support for caregivers. ?? Learn how you can contribute: https://lnkd.in/e8vTsDyA #NCFMonth #NationalFamilyCaregivingMonth #RAISECaregiving

Digital transformation doesn't have to be complicated! As featured in Pharma's Almanac, Josh Ludwig emphasizes the importance of simple, user-friendly tools for a successful transition. ScaleReady offers solutions that streamline operations and optimize your digital journey. Let's talk about how we can help you achieve your goals. https://lnkd.in/gxZTgyu5 #digitaltransformation #pharma #manufacturing #scaleready #pharmasalmanac